Brain Fog, Bloating, Breakouts? The Missing Link Between Gut Health & Hormones

If you’ve been struggling with persistent brain fog, stubborn bloating, or hormonal breakouts — and you’ve had your hormones tested but nothing obvious came up — there’s a conversation you may not have had yet: the one about your gut. The relationship between your gut microbiome and your hormonal health is one of the most under-appreciated connections in functional medicine. It’s not a fringe idea — it’s backed by a growing body of peer-reviewed research. And for many, understanding this relationship is the turning point that finally makes sense of their symptoms. In this post, we’re going to unpack exactly how your gut shapes your hormone health, why your liver and your microbiome work as a team to metabolise hormones like oestrogen, and what you can do clinically — including specific supplements and testing — to start addressing the root cause.

The Gut-Hormone Axis: More Than a Metaphor

Your gut does far more than digest food. It is an endocrine (hormonal) organ in its own right — home to over 100 million neurons, capable of producing and metabolising hormones, communicating directly with the brain via the vagus nerve, and profoundly influencing the immune system.

The gut microbiome — the trillions of bacteria, archaea, fungi, and other microorganisms living in your digestive tract — interacts with virtually every hormonal system in the body. This includes:

• Oestrogens (via the estrobolome)
• Thyroid hormones (via deiodinase enzyme activity and LPS-mediated inflammation)
• Cortisol and the HPA axis (via the gut-brain axis and immune signalling)
• Insulin and blood glucose regulation (via short-chain fatty acid production and GLP-1 secretion)
• Androgens (via bacterial biotransformation of steroid precursors)

Let’s start with the one that affects so many of my clients: oestrogen.

The Estrobolome: Your Gut’s Oestrogen-Regulating Community

The term estrobolome refers to the collection of gut bacterial genes capable of metabolising oestrogens [1]. For a deep dive on this check our our article The Estrobolome. This was first formally described by Plottel and Blaser in 2011 and has since become a significant area of research in female hormonal health, cancer biology, and metabolic medicine.

Here’s how it works.

Oestrogen Metabolism: A Two-Phase Story

Oestrogens produced in the ovaries, adrenal glands, and adipose tissue circulate in the bloodstream and must be broken down and eliminated. This happens primarily in the liver through a two-phase detoxification process:

Phase I (Oxidation): Cytochrome P450 enzymes (particularly CYP1A1, CYP1B1, and CYP3A4) convert oestradiol (E2) into hydroxylated metabolites — the 2-OH, 4-OH, and 16α-OH pathways. The 2-OH pathway is generally considered the “safer” pathway, while 4-OH and 16α-OH oestrones have been associated with greater proliferative and DNA-damaging potential [2].

Phase II (Conjugation): These oxidised metabolites are then conjugated — primarily via glucuronidation (mediated by UGT enzymes) and sulphation (mediated by SULT enzymes) — making them water-soluble and ready for excretion via bile into the gut.

This is where the gut microbiome enters the picture.

Enterohepatic Recirculation: The Loop That Changes Everything

Once conjugated oestrogen metabolites arrive in the gut via bile, the story doesn’t end there. If certain gut bacteria are present in high enough numbers, they can deconjugate these oestrogen metabolites using an enzyme called beta-glucuronidase [3].

Beta-glucuronidase cleaves the glucuronide group off the oestrogen, converting it back into its free, biologically active form. This deconjugated oestrogen can then be reabsorbed from the gut into the bloodstream — a process known as enterohepatic recirculation.

The consequence? Instead of being excreted in the stool, oestrogen re-enters the circulation. This creates a cycle of oestrogen re-exposure, which can tip the balance toward oestrogen dominance — a state in which oestrogen activity is disproportionate relative to progesterone or is simply elevated in absolute terms.

Oestrogen dominance has been associated with:

• Heavy, painful, or irregular periods
• PMS and premenstrual mood changes
• Fibroids and endometriosis
• Breast tenderness
• Weight gain, particularly around the hips and thighs
• Anxiety and mood instability
• And as we’ll explore below — brain fog and skin problems

Research published in Gut Microbes demonstrated that women with altered gut microbiome composition showed significantly higher circulating oestrogen levels — consistent with the hypothesis that disrupted estrobolome function drives enterohepatic recirculation of oestrogens [4].

The bacteria most commonly associated with high beta-glucuronidase activity include certain strains of Clostridium, Bacteroides, Escherichia, and Ruminococcus — and their relative abundance is shaped by diet, antibiotic exposure, stress, and gut dysbiosis [5].

Beyond Oestrogen: Other Hormones the Gut Influences

Thyroid Hormones

Around 20% of the conversion of inactive thyroid hormone T4 to active T3 occurs in the gut — facilitated by bacterial deiodinase activity. Dysbiosis can impair this conversion, contributing to hypothyroid-like symptoms even when TSH appears normal [6].

Furthermore, intestinal permeability (leaky gut — more on this shortly) allows lipopolysaccharide (LPS), an endotoxin released from gram-negative bacteria, to enter the bloodstream. LPS triggers systemic inflammation that directly suppresses thyroid function at the level of the hypothalamus and pituitary, as well as impairing cellular sensitivity to thyroid hormone [7].

Cortisol and the HPA Axis

The gut microbiome plays a major role in modulating the hypothalamic-pituitary-adrenal (HPA) axis — the stress-response system that governs cortisol secretion. Animal and human studies have shown that germ-free mice exhibit exaggerated stress responses compared to those with normal microbiota, and that probiotic supplementation can attenuate cortisol reactivity [8].

Short-chain fatty acids (SCFAs) produced by beneficial bacteria — particularly butyrate — appear to regulate HPA axis tone via epigenetic mechanisms and direct effects on the adrenal glands [9].

Chronically elevated cortisol, in turn, disrupts the gut barrier, suppresses secretory IgA (the gut’s front-line immune defence), and promotes dysbiosis — creating a vicious cycle between gut dysfunction and stress hormone imbalance.

Insulin and Metabolic Hormones

The gut microbiome regulates insulin sensitivity through multiple pathways: SCFA production stimulates GLP-1 secretion from enteroendocrine cells (improving glucose regulation), while LPS-driven inflammation impairs insulin receptor signalling and promotes metabolic endotoxaemia — a low-grade inflammatory state linked to insulin resistance, weight gain, and metabolic syndrome [10].

Androgens

Emerging research suggests that gut bacteria can biotransform glucocorticoids into androgens and influence androgen receptor signalling. In the context of PCOS, studies have noted that women with PCOS have significantly reduced gut microbial diversity and altered androgen metabolism compared to healthy controls [11]. This bidirectional relationship — where androgens shape the microbiome and the microbiome shapes androgen levels — is an active and exciting area of research.

Leaky Gut: The Inflammatory Amplifier

No discussion of gut-hormone connections would be complete without addressing intestinal hyperpermeability, more commonly known as leaky gut.

The intestinal epithelium is a single-cell-thick barrier between your gut lumen and your bloodstream. Under healthy conditions, tight junction proteins (occludin, claudin, and zonulin-regulated complexes) seal the gaps between these cells, allowing only properly digested nutrients to pass through.

When this barrier breaks down — due to dysbiosis, SIBO, food sensitivities, alcohol, NSAIDs, stress, or poor diet — the consequences extend well beyond the gut. Partially digested food particles, bacterial fragments (LPS), and other antigens enter the circulation, triggering a cascade of systemic immune activation [12].

This has profound implications for hormone balance:

• LPS directly inhibits steroidogenesis in the adrenal glands, blunting cortisol and DHEA output [13]
• Systemic inflammation dysregulates sex hormone binding globulin (SHBG), altering how much free oestrogen, testosterone, and other hormones are available at the tissue level
• Inflammatory cytokines (IL-6, TNF-α) interfere with oestrogen receptor sensitivity and progesterone signalling
• Impaired gut integrity reduces bile acid circulation, which further impairs oestrogen conjugation and elimination

The clinical implication: if your gut barrier is compromised, your hormones may be dysregulated even if your liver detoxification pathways are functioning well. Both must be addressed.

SIBO and Hormone Disruption: The Underdiagnosed Connection

Small Intestinal Bacterial Overgrowth (SIBO) — and particularly methane-dominant SIBO (now reclassified as Intestinal Methanogen Overgrowth, or IMO) — can profoundly affect hormone metabolism through several mechanisms:

• Impaired bile acid metabolism: Bacteria in the small intestine deconjugate bile acids prematurely, reducing their ability to emulsify fats and support the enterohepatic recirculation of fat-soluble nutrients needed for hormone synthesis (particularly cholesterol and fat-soluble vitamins)
• Increased intestinal permeability: SIBO is consistently associated with disrupted tight junction integrity, contributing to the leaky gut-hormone axis described above [14]
• Nutrient malabsorption: SIBO impairs absorption of zinc, magnesium, B6, and other nutrients critical to Phase I and Phase II liver detoxification of oestrogens
• Methane gas and motility: Methane produced by archaeal species (Methanobrevibacter smithii) slows gastrointestinal transit — impairing stool excretion of conjugated oestrogens and amplifying enterohepatic recirculation

Ongoing Gut Symptoms?

Shop our gut health tests

Brain Fog: Where Gut, Hormones, and Neuroinflammation Collide

Brain fog is one of the most commonly reported yet underappreciated symptoms in functional medicine. Patients describe it as difficulty concentrating, poor memory, mental fatigue, word-finding difficulties, and a sense of “thinking through cotton wool.”

It sits at the intersection of the gut-brain axis, hormonal health, and systemic inflammation — and understanding it requires thinking in systems.

The Gut-Brain Axis and Cognitive Function

The bidirectional communication between the gut and brain — via the vagus nerve, the enteric nervous system, the immune system, and circulating metabolites — means that gut dysfunction directly impairs brain function.

Key mechanisms include:

1. Systemic inflammation and neuroinflammation: LPS from leaky gut crosses the blood-brain barrier (or triggers brain-resident microglia remotely via inflammatory cytokines), activating neuroinflammation. This disrupts neurotransmitter synthesis, impairs hippocampal neurogenesis, and slows cognitive processing [15].

2. Tryptophan shunting: The gut microbiome regulates how dietary tryptophan is metabolised. In a healthy gut, tryptophan is preferentially converted to serotonin and kynurenic acid (neuroprotective). In dysbiosis, the IDO1 enzyme is upregulated by inflammatory signals, shunting tryptophan toward quinolinic acid — a potent neurotoxin associated with depression, anxiety, and cognitive decline [16].

3. Short-chain fatty acids: Butyrate — produced by bacteria fermenting dietary fibre — crosses the blood-brain barrier and directly supports microglial health, reduces neuroinflammation, and maintains blood-brain barrier integrity. Reduced butyrate production (a hallmark of dysbiosis) therefore compromises neurological resilience [17].

How Hormonal Imbalances Drive Brain Fog

Oestrogen and progesterone have well-established neuroactive roles:

• Oestradiol supports serotonin and dopamine synthesis, promotes synaptic plasticity, and protects neurons from oxidative damage. Deficiency or fluctuation — as occurs in perimenopause, luteal phase, or oestrogen dominance — impairs cognitive clarity [18].
• Progesterone converts to allopregnanolone, a potent positive modulator of GABA-A receptors. Low progesterone (which often accompanies oestrogen dominance due to relative insufficiency) reduces GABAergic tone — contributing to anxiety, poor sleep, and brain fog [19].
• Thyroid hormone is essential for neuronal myelination and mitochondrial energy production in the brain. Even subclinical hypothyroidism — including that driven by gut-mediated impaired T4→T3 conversion — produces measurable cognitive slowing [20].
• Cortisol dysregulation: Elevated cortisol suppresses hippocampal BDNF (brain-derived neurotrophic factor) and damages hippocampal neurons over time. Cortisol resistance — emerging from HPA axis disruption driven by gut dysfunction — leaves the brain in a state of low-grade inflammatory activation, impairing executive function and memory consolidation [21].

Skin Health: Reading Your Hormones Through Your Complexion

The skin is not a superficial organ — it is a neuroendocrine tissue that both produces and responds to hormones, and it reflects the functional status of the gut-liver axis with striking fidelity.

Oestrogen, Progesterone, and Acne

The relationship between hormonal fluctuations and acne is well established, particularly in women. Androgens (especially testosterone and its derivative DHT) stimulate sebaceous gland activity, increasing sebum production and creating the environment for Cutibacterium acnes colonisation and inflammation [22].

But the gut-hormone-skin connection runs deeper:

• Oestrogen dominance relative to progesterone alters the androgen-to-oestrogen ratio at the tissue level, often increasing localised androgen activity in sebaceous glands
• Elevated beta-glucuronidase activity — and the consequent enterohepatic recirculation of oestrogens — drives oestrogen dominance and its downstream effects on skin
• Dysbiosis and leaky gut trigger systemic inflammation that activates mTORC1, a key driver of sebocyte proliferation and hyperkeratinisation — the hallmarks of acne pathogenesis [23]

Research published in Nutrients demonstrated a significant association between gut dysbiosis and acne vulgaris, with altered Firmicutes-to-Bacteroidetes ratios and reduced diversity observed in acne patients [24].

The Gut-Skin Axis

The concept of a gut-skin axis — first proposed in the early 20th century and now substantiated by modern microbiome science — posits that gut permeability, microbial diversity, and systemic inflammation are primary drivers of inflammatory skin conditions including acne, eczema, psoriasis, and rosacea.

Substance P, released during gut-driven stress responses, directly stimulates sebum production and cutaneous inflammation. Meanwhile, gut-derived butyrate deficiency impairs skin barrier function by reducing ceramide synthesis — making the skin more susceptible to environmental triggers and inflammatory cascade [25].

How We Detoxify Hormones: A Deeper Look

Understanding how the body processes and eliminates hormones — particularly oestrogen — is essential context for the supplement recommendations below.

Hormone detoxification happens in three integrated phases:

Phase I: Bioactivation (Liver)

Cytochrome P450 enzymes hydroxylate oestrogen into reactive intermediates. Nutrients required: B vitamins (particularly B2, B3, B6), magnesium, and glutathione.

The 2-OH pathway is protective; 4-OH and 16α-OH metabolites are more reactive and require efficient Phase II handling to prevent DNA adduct formation.

Phase II: Conjugation (Liver)

The reactive intermediates are conjugated — primarily via glucuronidation (UGT enzymes, requiring glucuronic acid), sulphation (SULT enzymes, requiring sulphur), and methylation (COMT enzyme, requiring SAMe and magnesium). This makes oestrogen water-soluble and ready for elimination.

Nutrients required: sulphur-containing amino acids (glycine, cysteine, glutamate — for glutathione), SAMe, magnesium, DIM (diindolylmethane), calcium D-glucarate.

Phase III: Elimination (Gut)

Conjugated oestrogens are secreted in bile and excreted in stool. This phase depends entirely on healthy gut function, motility, and a balanced microbiome that doesn’t excessively deconjugate oestrogens via beta-glucuronidase.

If stool transit is slow — as in IMO or methane SIBO — conjugated oestrogens have more time to be deconjugated and reabsorbed, amplifying the enterohepatic cycle.

Supporting Detoxification: A Targeted Supplement Protocol

The following supplements have evidence-based rationale for supporting hormone detoxification, liver function, and gut health. These are commonly used in clinical practice and represent tools I reach for regularly when supporting clients with hormonal imbalances.

Note: These supplements are intended to complement a whole-food, fibre-rich diet.

1. Liver G.I. by Pure Maintenance

A comprehensive liver and gastrointestinal support formula that combines hepatoprotective botanicals (such as milk thistle/silymarin), gut-supportive nutrients, and detoxification co-factors. Milk thistle has demonstrated in clinical trials to protect liver cells from oxidative damage, support Phase II detoxification enzyme activity, and reduce systemic inflammation — all critical in the context of oestrogen metabolism [26].

Best suited for clients with sluggish liver function, elevated liver enzymes, or signs of oestrogen dominance with concurrent gut symptoms.

2. Amino D-Tox by Designs for Health

A comprehensive amino acid and botanical formula designed to support both Phase I and Phase II liver detoxification. It provides key amino acids — including glycine, taurine, cysteine, and glutamine — alongside N-acetyl cysteine (NAC) and methyl donors. These are the raw materials for glutathione synthesis and methylation (COMT pathway), both critical for processing oestrogen metabolites through Phase II.

Research confirms that taurine conjugation of bile acids improves bile flow and enhances elimination of oestrogen conjugates via the gut [27].

3. Calcium D-Glucarate

This is one of the most targeted interventions for oestrogen dominance via the estrobolome. Calcium D-glucarate is the calcium salt of D-glucaric acid, a compound found naturally in foods like broccoli, apples, and oranges. It inhibits beta-glucuronidase in the gut — directly blocking the deconjugation step in enterohepatic recirculation [28].

By inhibiting beta-glucuronidase, calcium D-glucarate essentially closes the loop on oestrogen recirculation, allowing conjugated oestrogen metabolites to be excreted rather than reabsorbed. Clinical data and animal studies support its use in reducing circulating oestrogen and improving the ratio of protective-to-proliferative oestrogen metabolites [29].

This is a foundational supplement for anyone with confirmed or suspected elevated beta-glucuronidase activity on a microbiome test, symptoms of oestrogen dominance, or conditions such as endometriosis.

4. DIM Ultra by Pure Encapsulations

DIM (3,3′-diindolylmethane) is a bioactive compound derived from cruciferous vegetables — the compound formed when indole-3-carbinol is digested. It has been extensively studied for its ability to modulate oestrogen metabolism, specifically by promoting the 2-OH pathway (protective) over the 4-OH and 16α-OH pathways (more proliferative) [2, 30].

DIM also appears to reduce the potency of oestrogen’s signalling on oestrogen-receptor-positive tissues, making it particularly relevant for those with endometriosis, fibroids, or breast tenderness. It supports Phase I CYP1A1 enzyme activity and has antioxidant properties that protect against reactive oestrogen metabolite DNA damage.

DIM Ultra uses a bioenhanced form with improved bioavailability — an important consideration, as plain DIM has variable absorption.

5. Liposomal Glutathione

Glutathione is the body’s master antioxidant and is central to Phase II liver detoxification — particularly for neutralising reactive oestrogen metabolites formed in Phase I (particularly the 4-OH catechol oestrogens, which form quinone intermediates capable of DNA damage) [31].

The challenge with oral glutathione supplementation is poor bioavailability — glutathione is largely broken down in the gastrointestinal tract before reaching systemic circulation. Liposomal delivery encapsulates glutathione in phospholipid vesicles that bypass gastrointestinal degradation, significantly improving intracellular delivery and clinical efficacy [32].

This is particularly valuable in clients with high toxic burden, environmental oestrogen exposure, or signs of oxidative stress (fatigue, slow recovery, recurrent illness).

6. Bitters No. 9

A sophisticated blend of traditional bitter botanicals — including gentian, dandelion, artichoke, and ginger — formulated as a nanoemulsion for rapid sublingual absorption. Bitter herbs have been used in herbalism and naturopathic medicine for centuries to support digestive function, and their mechanisms are now well understood.

Bitter compounds activate bitter taste receptors (TAS2Rs) in the mouth and gut, stimulating:

• Bile flow (cholagogue/choleretic effect): Increased bile secretion from the liver and gallbladder improves emulsification of fats and supports the excretion of oestrogen conjugates into the gut for elimination [33]
• Digestive enzyme secretion: Improved protein and fat digestion reduces the substrate available for dysbiotic bacteria and supports overall gut ecology
• Gastric motility: Enhanced gastric emptying and MMC (migrating motor complex) activity — directly relevant in SIBO and IMO management, where motility impairment is a key perpetuating factor

Quicksilver’s nanoemulsion technology ensures significantly enhanced bioavailability compared to traditional tinctures, making Bitters No. 9 a particularly potent clinical tool.

Where to Start: Testing Before Guessing

The single most important clinical principle in functional medicine is test, don’t guess. Symptoms like brain fog, bloating, and hormonal skin issues can have overlapping causes, and the wrong intervention — even a well-intentioned one — can miss the mark or worsen the picture.

Test, Don't Guess.

Shop our gut health tests

Practical Foundations: What Moves the Needle Daily

Alongside targeted testing and supplementation, these daily practices form the non-negotiable foundation of gut-hormone health:

Diet: A diverse, high-fibre diet rich in cruciferous vegetables (broccoli, Brussels sprouts, kale — natural sources of DIM and sulforaphane), fermented foods, and prebiotic fibres. Reducing ultra-processed foods, alcohol, and industrial seed oils reduces inflammatory burden on the gut and liver.

Bowel regularity: Daily, well-formed bowel movements are essential for oestrogen elimination. Constipation is one of the most underappreciated drivers of oestrogen dominance. Assess magnesium status, fibre intake, and hydration — and investigate SIBO/IMO if sluggish motility is persistent.

Stress management: The HPA-gut axis is bidirectional. Chronic stress degrades the gut barrier, suppresses beneficial bacteria, and amplifies cortisol dysregulation. Breathwork, HeartMath techniques, and somatic practices support HPA axis resilience.

Sleep: Growth hormone pulses during deep sleep support Phase I and Phase II liver function. Poor sleep independently disrupts sex hormone balance and increases cortisol — compounding the gut-hormone cycle.

Final Thoughts

Brain fog, bloating, and hormonal breakouts are not separate problems with separate solutions. They are often downstream expressions of the same upstream dysfunction: a gut that isn’t processing hormones efficiently, a liver under pressure, and an inflammatory environment that disrupts signalling from the brain to the skin.

The good news is that this system is responsive. With the right testing, targeted supplementation, and meaningful dietary and lifestyle changes, the gut-hormone axis can be rebalanced — and the symptoms that have been dismissed as “normal” can resolve.

References

1. Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011;10(4):324–335. doi:10.1016/j.chom.2011.10.003
2. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP. Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent. Ann N Y Acad Sci. 1999;889:204–213. doi:10.1111/j.1749-6632.1999.tb08736.x
3. Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst. 2016;108(8):djw029. doi:10.1093/jnci/djw029
4. Flores R, Shi J, Fuhrman B, et al. Fecal microbial determinants of fecal and serum estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012;10:253. doi:10.1186/1479-5876-10-253
5. Gérard P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens. 2014;3(1):14–24. doi:10.3390/pathogens3010014
6. Virili C, Centanni M. “With a little help from my friends” — the role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Mol Cell Endocrinol. 2017;458:39–43. doi:10.1016/j.mce.2017.01.053
7. Sarne D. Effects of the environment, chemicals and drugs on thyroid function. In: Feingold KR, et al., eds. Endotext. MDText.com; 2016.
8. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558(1):263–275. doi:10.1113/jphysiol.2004.063388
9. Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int. 2016;99:110–132. doi:10.1016/j.neuint.2016.06.011
10. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772. doi:10.2337/db06-1491
11. Qi X, Yun C, Sun L, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225–1233. doi:10.1038/s41591-019-0509-0
12. Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4):e1251384. doi:10.1080/21688370.2016.1251384
13. Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. 2012;1261:55–63. doi:10.1111/j.1749-6632.2012.06633.x
14. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture. Dig Dis Sci. 2012;57(5):1321–1329. doi:10.1007/s10620-012-2033-7
15. Erny D, Hrabě de Angelis AL, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965–977. doi:10.1038/nn.4030
16. O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32–48. doi:10.1016/j.bbr.2014.07.027
17. Bourassa MW, Alim I, Bultman SJ, Bhaskaran R. Butyrate, neuroepigenetics and the gut microbiome: can a high fibre diet improve brain health? Neurosci Lett. 2016;625:56–63. doi:10.1016/j.neulet.2016.02.009
18. Sherwin BB. Estrogen and cognitive functioning in women. Endocr Rev. 2003;24(2):133–151. doi:10.1210/er.2001-0016
19. Bäckström T, Haage D, Löfgren M, et al. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some patients. Neuroscience. 2011;191:46–54. doi:10.1016/j.neuroscience.2011.03.061
20. Samuels MH. Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr Opin Endocrinol Diabetes Obes. 2008;15(5):429–433. doi:10.1097/MED.0b013e32830eb84c
21. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10(6):434–445. doi:10.1038/nrn2639
22. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22(5):360–366. doi:10.1016/j.clindermatol.2004.03.004
23. Melnik BC. Acne vulgaris: the metabolic syndrome of the pilosebaceous follicle. Clin Dermatol. 2018;36(1):29–40. doi:10.1016/j.clindermatol.2017.09.006
24. Deng Y, Wang H, Zhou J, et al. Patients with acne vulgaris have a distinct gut microbiota in comparison with healthy controls. Acta Derm Venereol. 2018;98(8):783–790. doi:10.2340/00015555-2968
25. O’Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: a paradigm with therapeutic implications. Bioessays. 2016;38(11):1167–1176. doi:10.1002/bies.201600008
26. Vargas-Mendoza N, Madrigal-Santillán E, Morales-González A, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6(3):144–149. doi:10.4254/wjh.v6.i3.144
27. Mørkholt AS, Wiborg O, Nieland JGK, Nielsen S, Nieland JD. Conjugated linolenic acids and taurine: mechanisms and potential for chronic disease. Nutrients. 2017;9(10):1126. doi:10.3390/nu9101126
28. Walaszek Z, Hanausek-Walaszek M, Minton JP, Webb TE. Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis. Carcinogenesis. 1986;7(9):1463–1466. doi:10.1093/carcin/7.9.1463
29. Abou-Issa H, Moeschberger M, el-Masry W, Tejwani S, Curley RW Jr, Webb TE. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis. Anticancer Res. 1995;15(3):805–810.
30. Thomson CA, Ho E, Strom MB. Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: evidence from experimental and human studies. Nutr Rev. 2016;74(7):432–443. doi:10.1093/nutrit/nuw010
31. Lash LH, Hagen TM, Jones DP. Exogenous glutathione protects intestinal epithelial cells from oxidative injury. Proc Natl Acad Sci USA. 1986;83(14):4641–4645. doi:10.1073/pnas.83.14.4641
32. Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2018;72(1):105–111. doi:10.1038/ejcn.2017.132
33. Lv X, Zhao S, Ning Z, et al. Citrus fruits as a treasure trove of active natural metabolites that potentially provide benefits for human health. Chem Cent J. 2015;9:68. doi:10.1186/s13065-015-0145-9